1383744-17-9

Basic information

• Product Name: 3-(1-(3-tert-butyl-4-methoxybenzyl)piperazine-4-yl)-2-hydroxy-1-propanesulfonic acid potassium salt
• Synonyms: 3-(1-(3-tert-butyl-4-methoxybenzyl)piperazine-4-yl)-2-hydroxy-1-propanesulfonic acid potassium salt
• CAS NO: 1383744-17-9
• Molecular Weight: 438.63
• Mol File: 1383744-17-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(1-(3-tert-butyl-4-methoxybenzyl)piperazine-4-yl)-2-hydroxy-1-propanesulfonic acid potassium salt(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(1-(3-tert-butyl-4-methoxybenzyl)piperazine-4-yl)-2-hydroxy-1-propanesulfonic acid potassium salt(1383744-17-9)
• EPA Substance Registry System: 3-(1-(3-tert-butyl-4-methoxybenzyl)piperazine-4-yl)-2-hydroxy-1-propanesulfonic acid potassium salt(1383744-17-9)

Safety Data

• Hazardous Substances Data: 1383744-17-9(Hazardous Substances Data)

Upstream product

• 107430-92-2 3-tert-butyl-4-methoxybenzaldehyde 
• 1383744-25-9 N-(tert-butyloxycarbonyl)-N'-(3-tert-butyl-4-methoxybenzyl)-piperazine 
• 126-83-0 sodium 3-chloro-2-hydroxypropane-sulfonate 

Relevant articles and documents

N,N+hu 1 +l SUBSTITUTED PIPERAZINES HAVING COMBINED ANTIAGGREGANT, ANTICOAGULANT AND VASODILATORY ACTIVITY, AND METHOD FOR PRODUCING SAME

The invention relates to derivatives of N,N′-substituted piperazines of the general formula (I): where R1 and R2 denote linear or branched (C1-C4)alkyl, linear or branched (C1-C4)alkoxy, CH